SCHEMBL3148356

SCHEMBL3148356

CCCCCCCCCCCCCCCCCCCCCC(=O)On1nnc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 1/20 0.59
ASAH1 Q13510 1/20 0.53
SLC9A1 P19634 4/20 0.52
HDAC3 O15379 3/20 0.51
HDAC4 P56524 3/20 0.51
HDAC1 Q13547 3/20 0.51
HDAC7 Q8WUI4 3/20 0.51
HDAC2 Q92769 3/20 0.51
HDAC10 Q969S8 3/20 0.51
HDAC11 Q96DB2 3/20 0.51
HDAC8 Q9BY41 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
HDAC9 Q9UKV0 3/20 0.51
HDAC5 Q9UQL6 3/20 0.51
SIRT2 Q8IXJ6 3/20 0.49
CYP4Z1 Q86W10 4/20 0.49
MGAM O43451 1/20 0.48
AMY1A P0DUB6 1/20 0.48
GAA P10253 1/20 0.48
SI P14410 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3133609 1.00 HPSE (0.59) HPSEASAH1SLC9A1HDAC3HDAC4
SCHEMBL11601557 1.00 HPSE (0.59) HPSEASAH1SLC9A1HDAC3HDAC4
SCHEMBL3148419 1.00 HPSE (0.59) HPSEASAH1SLC9A1HDAC3HDAC4
SCHEMBL6552751 0.99 HPSE (0.57) HPSEASAH1SLC9A1HDAC3HDAC4
SCHEMBL2216539 0.93 SIRT2 (0.55) HPSEHDAC3HDAC4HDAC1HDAC7
SCHEMBL11752297 0.92 SIRT2 (0.56) HPSEHDAC3HDAC4HDAC1HDAC7
SCHEMBL15701333 0.89 HDAC3 (0.56) HPSEASAH1SLC9A1HDAC3HDAC4
SCHEMBL4952678 0.89 SIRT2 (0.56) HPSEHDAC3HDAC4HDAC1HDAC7
SCHEMBL13782023 0.86 CYP4Z1 (0.51) HPSEASAH1HDAC3HDAC4HDAC1
SCHEMBL14423593 0.84 ASAH1 (0.53) HPSEASAH1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1640383-B1 DISIALOUNDECASACCHARIDE CHAIN ASPARAGINE/FATTY ACID AMIDE AND MEDICAL DRUG CONTAINING THE SAME GLYTECH INC (JP) 2014-02-19 EP disclosed
US-7687478-B2 Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same OTSUKA CHEMICAL CO., LTD. (JP) 2010-03-30 US disclosed
US-20070105813-A1 Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same OTSUKA CHEMICAL CO., LTD. (JP) 2007-05-10 US disclosed
EP-1640383-A1 DISIALOUNDECASACCHARIDE CHAIN ASPARAGINE/FATTY ACID AMIDE AND MEDICAL DRUG CONTAINING THE SAME OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2006-03-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105813-A1 Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same ASNS, FASN, SCD HPSE 121/4885ASAH1 57/4885SLC9A1 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.